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Abstract
Background: Ganghwaljetongyeum (GHJTY) is a complex herbal decoction comprising 18 plants; it is used to treat
arthritis. In order to develop a new anti-arthritic herbal medication, we selected 5 out of 18 GHJTY plants by using
bioinformatics analysis. The new medication, called ChondroT, comprised water extracts of Osterici Radix, Lonicerae
Folium, Angelicae Gigantis Radix, Clematidis Radix, and Phellodendri Cortex. This study was designed to investigate
its chondroprotective and anti-inflammatory effects to develop an anti-arthritic herb medicine.
Methods: ChondroT was validated using a convenient and accurate high-performance liquid chromatography–
photodiode array (HPLC–PDA) detection method for simultaneous determination of its seven reference
components. The concentrations of the seven marker constituents were in the range of 0.81–5.46 mg/g. The
chondroprotective effects were evaluated based on SW1353 chondrocytes and matrix metalloproteinase 1
(MMP1) expression. In addition, the anti-inflammatory effects of ChondroT were studied by Western blotting of
pro-inflammatory enzymes and by enzyme-linked immunosorbent assay (ELISA) of inflammatory mediators in
lipopolysaccharides (LPS)-induced RAW264.7 cells.
Results: ChondroT enhanced the growth of SW1353 chondrocytes and also significantly inhibited IL-1β-induced
MMP-1 expression. However, ChondroT did not show any effects on the growth of HeLa and RAW264.7 cells. The
expression of cyclooxygenase-2 (COX-2) and inducible nitric oxide synthase (iNOS) was induced by LPS in
RAW264.7 cells, which was significantly decreased by pre-treatment with ChondroT. In addition, ChondroT
reduced the activation of NF-kB and production of inflammatory mediators, such as IL-1β, IL-6, PGE2, and nitric
oxide (NO) in LPS-induced RAW264.7 cells.
Conclusions: These results show that ChondroT exerted a chondroprotective effect and demonstrated multi-target
mechanisms related to inflammation and arthritis. In addition, the suppressive effect was greater than that exhibited by
GHJTY, suggesting that ChondroT, a new complex herbal medication, has therapeutic potential for the treatment of
arthritis.
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Background
Arthritis is the most common inflammatory disease and a
major public concern in elderly individuals. The symp-
toms include joint pain, tenderness, and joint inflamma-
tion. Although rheumatoid arthritis and osteoarthritis
differ fundamentally in several respects, they result in car-
tilage degradation, which in turn leads to cartilage bone
damage [1]. Matrix metalloproteases (MMPs) play a crit-
ical role in the breakdown of cartilage [2, 3]. In particular,
MMP-1 is known to decompose type II collagen, which is
a major component of chondrocytes [4]. Cartilage degrad-
ation in arthritis is recognized to be induced by inflamma-
tory cytokines, such as interleukin (IL)-6, IL-1β, and
tumor necrosis factor-α (TNF-α) [5–7]. Recently, prosta-
glandin E2 (PGE2) or nitric oxide (NO) has been shown to
play key roles in the induction of MMP expression in
chondrocytes [8, 9]. In addition to chondrocytes, macro-
phages contribute to inflammation and matrix degrad-
ation in osteoarthritis tissues, and inflammatory mediators
such as IL-1β, TNF-α, IL-6, PGE2, and NO represent po-
tential targets for osteoarthritis disease modification [9].
Proinflammatory enzymes such as cyclooxygenase-2
(COX-2) and inducible nitric oxide synthase (iNOS) that
cause pain and inflammation, provide a measure to assess
the effect of drugs for the treatment of arthritis [10]. Non-
steroidal anti-inflammatory drugs (NSAIDs) and selective
COX-2 inhibitors are pharmacological treatments used for
arthritis. Some oriental medicines have been used to treat
arthritis [11–13]. We reported that Ganghwaljetongyeum
(GHJTY), a traditional Korean herbal medicine used to
treat severe joint pain, limitation of motion, fever, and
swelling, inhibited inflammatory processes associated with
arthritis [14]. Because GHJTY is a complex herbal decoc-
tion composed of 18 plants, we selected 5 effective herbs,
i.e., Osterici Radix, Lonicerae Folium, Angelicae Gigantis
Radix, Clematidis Radix, and Phellodendri Cortex, using
bioinformatics analysis to develop a new anti-arthritic
herbal medication [15]. In the present study, the water ex-
tracts of these 5 herbs named ChondroT was evaluated as
an anti-arthritic herb drug. To develop a multi-functional
herbal medicine for arthritis, we tested the effects of
ChondroT on various arthritis-related pathomechanisms.
The effects of ChondroT were evaluated on SW1353
chondrocyte protection and IL-1β-induced MMP1 expres-
sion. In addition, the inhibitory effects of ChondroT were
studied on the expression of inflammatory enzymes COX-
2 and iNOS and on the production of inflammatory medi-




The five herbal medicines forming ChondroT –Oster-
ici Radix, Lonicerae Folium, Angelicae Gigantis Radix,
Clematidis Radix, and Phellodendri Cortex – listed in
Table 1 were purchased from Omniherb (Yeongcheon,
Korea). The origin of the five herbal medicines was
confirmed taxonomically by Professor Jong-Kil Jeong, Dept.
of Herbology, College of Oriental Medicine, Dongshin
University, Republic of Korea. Voucher specimens (KYR2014-
020) have been deposited at college of Pharmacy, Chonnam
National University.
Preparation of ChondroT
We combined 5 herbs containing Osterici Radix, Lonicerae
Folium, Angelicae Gigantis Radix, Clematidis Radix, and
Phellodendri Cortex in a ratio listed in Table 1. ChondroT
herb material composed of above 5 herbs was extracted
once using 10-fold water solvent at 100 °C for 3 h and then
filtered (180 mesh). The water extract solution of Chon-
droT was concentrated using a continuous vacuum evapor-
ator (around 55 ~ 60 °C, 670 mmHg) followed by
lyophilization using a vacuum drier (720 mmHg) for 8 h.
The water extract from GHJTY herbs was prepared as pre-
viously described [14]. Stock solutions of ChondroT and
GHJTY were prepared in a concentration of 50 mg/mL
using phosphate buffered saline (PBS) and filter-steriled.
Table 1 Composition of ChondroT
Latin name Scientific name Family w/w % Source





















Table 2 Reference compounds for quality control of ChondroT
Compound Purity (%) Company Detection wave
length (nm)
Chlrogenic acid ≥ 99.0 Acros Organics
(Pittsburgh, PA, USA)
325
Berberine Cl ≥ 98.0 Sigma-Aldrich Co.
(St. Louis, MO, USA)
340
Nodakenin ≥ 98.0 NPC BioTechnology
(Yeongi, Korea)
335








Decursin ≥ 98.0 NPC BioTechnology
(Yeongi, Korea)
330
Decursinol angelate ≥ 98.0 NPC BioTechnology
(Yeongi, Korea)
330
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Fig. 1 Chemical structure of the seven marker compounds (a) and HPLC chromatogram of a standard solution (b) and ChondroT (c) with
detection at 310 nm (I), 325 nm (II), 330 nm (III), 335 nm, and 340 nm (V). Chlorogenic acid (1), berberine Cl (2), nodakenin (3), isoferulic acid (4),
oxypeucedanin hydrate (5), decursin (6), and decursinol angelate (7)
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Reagents and high-performance liquid chromatography
(HPLC) analysis
Seven reference compounds used for quality control of
ChondroT are shown in Table 2. The chemical struc-
tures of the seven marker compounds are shown in
Fig. 1a. HPLC-grade solvents, methanol, acetonitrile, and
water were obtained from J.T. Baker (Phillipsburg, NJ,
USA). Analytical grade formic acid was purchased from
Sigma-Aldrich (St. Louis, MO, USA). All reference com-
pounds were dissolved in methanol at 1.0 mg/mL and
stored at 4 °C. Working standard solutions were pre-
pared by serial dilution of the stock solutions with
methanol. For HPLC analysis, lyophilized ChondroT
(200 mg) was dissolved in 20 mL of 70 % methanol and
extracted for 60 min by sonication. All the stock solu-
tions and ChondroT extract were passed through a 0.2-
μm syringe filter (Woongki Science, Seoul, Korea) before
HPLC analysis. The chromatographic analysis was con-
ducted using a Shimadzu Prominence LC-20A series sys-
tem (Shimadzu, Kyoto, Japan) consisting of a solvent
delivery unit (LC-20AT), online degasser (DGU-20A3), col-
umn oven (CTO-20A), auto sample injector (SIL-20 AC),
and photodiode array (PDA) detector (SPD-M20A). Data
were acquired and processed using Labsolution software
(version 5.54 SP3, Shimadzu, Kyoto, Japan). The column
used was Waters SunFire C18 (5 μm, 4.6 × 250 nm, Milifird,
MA, USA). The flow rate was kept constant at 1.0 mL/min,
while the column temperature was maintained at 40 °C,
and the injection volume was 10 μL. The gradient elution
of two mobile phase systems with 0.1 % (v/v) formic acid in
water (solvent A) and 0.1 % (v/v) formic acid in acetonitrile
(solvent B) was as follows: 10–100 % B for 0–30 min,
100 % B for 30–40 min, and 100–10 % B for 40–50 min,
with a re-equilibrium time of 10 min.
Cell cultures
SW1353 chondrosarcoma cells, RAW264.7 macro-
phage cells, and 293T human kidney epithelial cells
were purchased from American Type Culture Collec-
tion (Manassas, VA, USA) and HeLa human cervix
epithelial cells were supplied from Korea Cell Line
Bank (Korea). The cells were cultured in Dulbecco
Modified Eagle’s medium (DMEM) (Welgene, Korea)
supplemented with 1 % penicillin-streptomycin and
10 % fetal bovine serum (FBS) (Gibco BRL, Rockville,
MD, USA) under an atmosphere of 5 % CO2 in a hu-
midified 37 °C incubator.
MTS assay for cell viability test
SW1353, HeLa, or RAW264.7 cells were seeded in 96
well plates (SPL life sciences Co., Pocheon, Korea) at
0.5–1.0 × 104/well. The cells were treated with Chon-
droT or GHJTY for 48 h. Cell proliferation was
assayed using 3-(4, 5-dimethylthiazol-2-yl)-5-(3-car-
boxymethoxyphenyl) - 2-(4-sulfophenyl)-2H-tetrazo-
lium (MTS), according to manufacturer’s instructions
(Promega, Madison, WI, USA). Absorbance was read
with an ELISA microplate reader (ELx808) (BioTek
Instruments, Inc., Winooski, VT, USA) at 490 nm.
Western blot analysis of MMP1
Human SW1353 chondrosarcoma cells were cultured in
a 6-well plate (SPL life sciences Co., Pocheon, Korea) at
5 × 105/well for 24 h. The cells were pretreated with
Table 3 Regression equations, linearity, LOD, and LOQ of the 7 marker compounds
Compound Linear range
(μg/mL)




Chlorogenic acid 1.56–100.00 y = 30,420.94x – 42,881.66 0.9996 0.03 0.10
Berberine Cl 0.78–50.00 y = 81,886.13x + 16,338.31 0.9999 0.01 0.02
Nodakenin 0.78–50.00 y = 43,427.95x + 6,116.21 0.9999 0.02 0.06
Isoferulic acid 0.78–50.00 y = 44,822.70x – 7,991.61 1.0000 0.02 0.07
Oxypeucedanin hydrate 1.56–100.00 y = 26,221.17x + 5,076.06 1.0000 0.04 0.12
Decursin 0.78–50.00 y = 37,915.21x + 52,952.92 1.0000 0.04 0.12
Decursinol angelate 0.78–50.00 y = 28,967.64x + 29,015.53 1.0000 0.05 0.16
ay: peak area (mAU) of compounds; x: concentration (μg/mL) of compounds
bLOD = 3 × 3.3 × standard deviation of blank / slope of regression
cLOQ = 10 × standard deviation of blank / slope of regression
Table 4 Amounts of the seven marker components in the
ChondroT by HPLC (n = 3)
Compound Mean (mg/g) SD × 10−1 RSD (%) Source
Chlorogenic acid 5.46 0.33 0.61 L. japonica
Berberine Cl 1.87 0.29 1.56 P. amurense
Nodakenin 1.70 0.18 1.06 A. gigas
Isoferulic acid 1.64 0.58 3.53 C. chinensis
Oxypeucedanin
hydrate
2.03 0.33 1.65 O. koreanum
Decursin 1.09 0.02 0.16 A. gigas
Decursinol angelate 0.81 0.01 0.15 A. gigas
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ChondroT or GHJTY (0.3 mg/mL) for 2 h and then IL-
1β or PMA (10 ng/mL) (Sigma Co., St. Louis, MO, USA)
was added to the cells for 24 h. Equal amounts of cell
supernatants were concentrated by acetone followed by
boiling in sample buffer (Bio-solution, Suwon, Korea) for
10 min. The samples were subjected to 12 % SDS-PAGE
and electro-transferred onto a nitrocellulose membrane
(Millipore, Bedford, MA, USA). The membrane was
blocked with 5 % skim milk and probed with an MMP1
antibody (Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA) and rabbit IgG-HRP second antibody (Dako,
Japan). The blots were washed three times using Tris-
buffered saline with 0.1 % Tween 20 (TBST) and
visualized using enhanced electrochemiluminescent
(ECL) Western blotting detection kit (Advansta Corp.,
Menlo Park, CA, USA). The relative amount of
MMP1 protein was analyzed by azure c-300 (Azure
Biosystems, CA, USA).
Western blot analysis of COX-2 and iNOS
RAW264.7 cells were cultured in a 6-well plate at 1 ×
106/well for 4 h. The cells were pretreated with Chon-
droT, GHJTY, or celecoxib (20 μM) (Sigma Co., MO,
USA) for 2 h and then LPS (500 ng/mL) (Sigma Co.,
MO, USA) was added to the cells for 24 h. Equal
amounts of cell lysates (25 μg) were subjected to 10 %
SDS-PAGE and electro-transferred onto polyvinylidene
fluoride membranes (PVDF) (Millipore, Bedford, MA,
USA). Western bot analysis was conducted using the
above mentioned methods with polyclonal antibodies
specific to COX-2 (Cell signaling Tech., Danvers, MA,
USA), iNOS (Santa Cruz Biotechnology Inc., Santa Cruz,
CA, USA), or GAPDH (Santa Cruz Biotechnology Inc.,
Santa Cruz, CA, USA).
Enzyme-linked immunosorbent assay (ELISA) of
proinflammatory cytokines
RAW264.7 cells were cultured at 1 × 105/well in 48-well
plates (SPL life sciences Co., Pocheon, Korea) for 24 h.
The cells were washed with fresh medium and treated
with ChondroT or GHJTY (1, 0.3, or 0.1 mg/mL) for
2 h, followed by treatment with 500 ng/mL LPS (Sigma
Co., MO, USA) for 24 h. IL-6 (Biolegend, San Diego,
CA, USA), TNF-α (R&D system, Minneapolis, MN,
USA), IL-1β (R&D System, Minneapolis, MN, USA), and
PGE2 (R&D system, Minneapolis, MN, USA) in the su-
pernatants were measured using ELISA kits following
the manufacturer’s experimental protocols. The assay
was performed at room temperature and the optical
absorbance was measured at 450 nm using an ELISA
microplate reader (ELx808) within 30 min.
Griess assay
The NO in the culture supernatant was measured using
Griess Reagent (1 % sulfanil-amide in 2.5 % H3PO4,
0.1 % N-(1-naphthyl)-ethylendiamine dihydrochloride).
The cell culture supernatant was blended with Griess














































Fig. 2 Effects of ChondroT on the proliferation of SW1353 chondrocyte
cells. a SW1353 cells were exposed to GHJTY or ChondroT for 2 days,
and the cell proliferation was assayed by MTS. ChondroT increased the
proliferation of SW1353 cells at concentrations of 0.1 ~ 1.0 mg/mL.
HeLa cells (b) or RAW264.7 cells (c) were treated with GHJTY or
ChondroT for 2 days, and the cell proliferation was assayed by MTS.
ChondroT did not show any cytotoxic effect on HeLa and RAW264.7
cells. *P < 0.05 and ***P < 0.001 compared to the untreated group
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Reagent for 30 min, and the absorbance was read at
570 nm using an ELISA microplate reader (ELx808).
DNA transfection and NF-kB reporter assays
Transient transfection of a reporter plasmid, pNF-kB-
SEAP (Clontech Laboratories, Inc., Palo Alto, CA, USA)
was performed for 293T cells seeded at 1 × 104/well in a
96-well plate using Lipofectamine 3000 (Invitrogen,
Carlsbad, MA, USA). One day after transfection, the cell
medium was replaced with fresh DMEM and treated
with ChondroT or GHJTY (0.3 and 0.1 mg/mL) for 4 h.
The cells were treated overnight with PMA (Sigma Co.,
St. Louis, MO, USA) at a concentration of 1 ng/mL. The
supernatants were incubated with QUANTI-Blue
(Invitrogen, Carlsbad, MA, USA) for 2–4 h, and the ab-
sorbance was read at 630 nm with an ELISA microplate
reader (ELx808).
DPPH radical scavenging activity
Radical scavenging activity was measured using 2, 2-
diphenyl-1-picrylhydrazyl (DPPH) (Sigma Co., St. Louis,
MO, USA) and butylated hydroxyanisole (BHA) (Sigma
Co., St. Louis, MO, USA) and vitamin C (VtC) (Sigma
Co., St. Louis, MO, USA) were used as positive anti-
oxidant drugs. ChondroT and other drugs dissolved in
methanol were mixed with DPPH (0.15 mM) in a 96-
well plate at room temperature for 30 min. The decrease
in absorbance was measured at 470 nm using an ELISA
microplate reader (ELx808).
Statistical analysis
All studies were repeated at least three times. Statistical
differences were evaluated using one way ANOVA. P
value <0.05 was considered significant.
Results
The quality assessment of seven marker components in
ChondroT
The HPLC-PDA method was developed for simultan-
eous determination of the quality assessment of seven
marker components in ChondroT, which was composed
of five medicinal herbs, Ostericum koreanum Maximo-
wicz (Osterici Radix), Lonicera japonica Thunberg (Loni-
cerae Folium), Angelica gigas Nakai (Angelicae Gigantis
Radix), Clematis mandshurica Ruprecht (Clematidis
Radix), and Phellodendron amurense Ruprecht (Phello-
dendri Cortex). In this study, the seven compounds, oxy-
peucedanin hydrate from Osterici Radix, chlorogenic
acid from Lonicerae Folium, nodakenin, decursin, and
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Fig. 3 Effects of ChondroT on MMP1 expression in IL-1β- or PMA-activated SW1353 cells. SW 1353 cells were pretreated with or without ChondroT or
GHJTY at a concentration of 0.3 mg/mL for 1 h and were then stimulated with PMA (a) or IL-1β (b). After 24 h, the MMP1 level was detected in cell
culture supernatants using Western blot analysis. ChondroT reduced MMP1 expression in IL-1β- or PMA-activated SW1353 cells
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isoferulic acid from Clematidis Radix, and berberine Cl
from Phellodendri Cortex were selected as marker com-
pounds for quality control of ChondroT. The calibration
curves of the seven marker components showed good
linearity with a correlation coefficient (r2) ≥ 0.9996 in the
different concentration ranges, and the other parameters
were shown in Table 3. Using optimized chromatog-
raphy conditions, the seven marker compounds were
separated within 30 min. The typical HPLC chromato-
gram of ChondroT is shown in Fig. 1b and 1c. The re-
tention times of the seven components, chlorogenic
acid, berberine Cl, nodakenin, isoferulic acid, oxypeuce-
danin hydrate, decursin, and decursinol angelate were
8.94, 10.80, 12.00, 12.86, 15.95, 26.02, and 26.24 min,
respectively. The amounts of the seven compounds
were 0.81–5.46 mg/g, and the results are summarized
in Table 4.
Effects of ChondroT on the proliferation of SW1353 cells
The most predominant pathological change during osteo-
arthritis is cartilage degradation. To evaluate the effect on
cartilage protection, SW1353 cells were treated with
ChondroT or GHJTY for 2 days, and the cell proliferation
was evaluated by MTS. ChondroT significantly increased
the proliferation of SW1353 cells at concentrations of 0.1
~ 1.0 mg/mL (Fig. 2a). In contrast, ChondroT and GHJTY
did not show any cytotoxic effect on other origin cells,
RAW264.7 and HeLa cells, at concentrations of 1, 0.3,
and 0.1 mg/mL (Fig. 2b and 2c). This result suggests that
ChondroT has specific proliferation activity on human-
born fibroblast SW1353 cells.
Effects of ChondroT on MMP1 expression in IL-1β- or
PMA-induced SW1353 cells
MMPs play a critical role in cartilage destruction in
arthritic joints, and MMP-1 is known to decompose a
major component of chondrocytes. The effect of Chon-
droT was evaluated on MMP1 expression in SW1353
cells induced by IL-1β or PMA using Western blotting.
MMP-1 expression was significantly increased by IL-1β
or PMA in SW1353 cells, which was decreased by pre-
treatment with ChondroT (Fig. 3). ChondroT showed in-
hibitory effect on MMP1 expression in SW1353 cells
greater than GHJTY (Fig. 3).
Effects of ChondroT on the expression of COX-2 and iNOS
in LPS-activated RAW264.7 cells
Proinflammatory enzymes, such as COX-2 and iNOS,
cause pain and inflammation during arthritis. RAW264.7
cells were pretreated with GHJTY or ChondroT and LPS
was added to the cells for 24 h. ChondroT significantly
reduced the expression of COX-2 and iNOS in LPS-
a b
Fig. 4 Effects of ChondroT on the induction of COX-2 and iNOS in LPS-activated RAW264.7 cells. RAW264.7 cells were pretreated with ChondroT for
2 h, and then LPS was added to the cells for 18 h. Beta actin was used as the control protein. The protein levels of COX-2 (a) and iNOS (b) were
detected by Western blot analysis. Celecoxib (Cel) and ChondroT reduced the expression of COX-2 and iNOS in LPS-activated RAW264.7 cells
Park et al. BMC Complementary and Alternative Medicine  (2016) 16:213 Page 7 of 11
activated RAW264.7 cells similar to celecoxib (Cel), a
COX-2 inhibitor (Fig. 4). The inhibitory effect of Chon-
droT on COX-2 and iNOS expression was greater than
that exhibited by GHJTY (Fig. 4).
Effects of ChondroT on the production of inflammatory
mediators in LPS-activated RAW264.7 cells
RAW264.7 cells were pretreated with ChondroT or
GHJTY for 2 h prior to addition of LPS (500 ng/mL). IL-
1β, TNF-α, IL-6, and PGE2 cytokines were assayed using
ELISA kits. ChondroT significantly decreased the pro-
duction of IL-1β, IL-6, and PGE2 in RAW264.7 cells ac-
tivated with LPS (Fig. 5a, b, and c). NO production in
LPS-activated RAW264.7 cells was also decreased by the
pretreatment of ChondroT (Fig. 5d). The inhibitory ef-
fect of ChondroT on inflammatory mediator production
was greater than that exhibited by GHJTY.
Effects of ChondroT on PMA-induced NF-kB activation in
293T cells
NF-kB is a transcription factor related to inflammation
and arthritis. The effect of ChondroT was tested on NF-
kB activation in 293T cells. PMA increased NF-kB
transcription, which was decreased by ChondroT pre-
treatment (Fig. 6). The inhibitory effect of ChondroT on
PMA-induced NF-kB activation was greater than that
exhibited by GHJTY.
Anti-oxidant activity of ChondroT
To study the anti-oxidant activity of the ChondroT, the
DPPH scavenging potential was determined. Vitamin C
and BHA were used as the positive controls. DPPH free
radicals were decreased by approximately 95 % at
0.3 mg/mL ChondroT and the inhibitory effect was
greater than that exhibited by GHJTY (Fig. 7).
Discussion
In this study, we evaluated the multifunctional effects of
ChondroT, a new complex herbal medication, for arthritis
pharmacologic treatment. ChondroT is a water extract of
5 herbs, Osterici Radix, Lonicerae Folium, Angelicae
Gigantis Radix, Clematidis Radix, and Phellodendri





Fig. 5 Effects of ChondroT on the production of pro-inflammatory
cytokines in LPS-activated RAW264.7 cells. RAW264.7 cells were
pretreated with ChondroT for 2 h and then incubated with LPS for
24 h. Inflammatory mediators were measured in the cell supernatants
by ELISA. ChondroT decreased the LPS-induced production of IL-1β (a),
IL-6 (b), and PGE2 (c). NO in the supernatant was detected by Griess
reagent (d). LPS-induced NO production in RAW264.7 cells was
decreased by ChondroT treatment. +P < 0.01 and +++P < 0.001
compared with the untreated group. *P < 0.05, **P < 0.01, and
***P < 0.001 compared with the LPS-treated group
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(GHJTY), a traditional Korean herbal medicine comprised
with 18 herbs, attenuates synoviocyte proliferation and re-
duces the production of proinflammatory mediators in
macrophages [14]. GHJTY as an anti-arthritic drug may
be limited because it is composed of 18 plants. To reduce
the numbers of plants and to increase the potency as
multifunctional anti-arthritic drugs, we conducted bio-
informatics analysis [15]. In addition, oriental clinical doc-
tors also suggested 4 complex herb medication candidates
according to their clinical experiences. We compared the
inhibitory effects of GHJTY and 4 complex herb medica-
tions on COX-2 and iNOS expression. Among them, an
herb material ChondroT showed the most potent activity in
chondrocyte protective effects and anti-inflammatory
effects. ChondroT enhanced the proliferation chondrocytes
(Fig. 2a) and also significantly inhibited IL-1β- or PMA-
induced MMP-1 expression in the chondrocytes (Fig. 3). In
addition, ChondroT decreased the expression of inflamma-
tory enzymes COX-2 and iNOS (Fig. 4) and reduced the
production of inflammatory mediators, such as IL-1β,
IL-6, PGE2, and NO, thereby playing important roles in
arthritis (Fig. 5). ChondroT also decreased the PMA-
induced activation of NF-kB, a transcription factor
related to inflammation and arthritis (Fig. 6). These re-
sults show that ChondroT exerted a chondroprotective
effect and demonstrated a multi-target mechanism on
inflammation and arthritis.
Oxidative stress was reported to induce apoptic cell
death of chondrocytes and excessive production of various
inflammatory cytokines in osteoarthritis, which further
promote the expression of MMPs [16, 17]. Polysaccharide
from Angelica sinensis was reported to protect chondro-
cytes from H2O2-induced apoptosis through its antioxi-
dant effects in vitro [18]. The anti-oxidant effects of
ChondroT (Fig. 7) can help patients suffering arthritis.
These results suggest that ChondroT composed of 5 herbs
has therapeutic potential for the treatment of arthritis.
Arthritis has become a significant clinical problem
worldwide with an increase in the aging populations.
NSAIDs and selective COX-2 inhibitors are used for
pharmacologic treatment of arthritis. Recent study
showed that celecoxib, a COX-2 inhibitor decreased NO
production in chondrocytes from osteoarthritic rat joints
and reduced inflammation by blocking NF-kB activation
in a murine model [19–22]. However, some patients
treated with these drugs complained of side effects such
as gastrointestinal, cardiovascular, and other complica-
tions. Our results show that the suppressive effect of
ChondroT on COX-2 and iNOS expression was similar
that exhibited by celecoxib, a COX-2 inhibitor used for
the treatment of arthritis (Fig. 4). In addition, ChondroT
did not show any cytotoxicity to various origin cells
(Fig. 2a, b, and c). Traditional herb medications have
been concerned for the treatment of arthritis. Recently,
SKI306X (Joins), an oriental herbal mixture were devel-
oped for osteoarthritis patients [1, 23–25].
ChondroT is a water extract of 5 herbs, Osterici
Radix, Lonicerae Folium, Angelicae Gigantis Radix,
Clematidis Radix, and Phellodendri Cortex. Effect of
Phellodendri Cortex was reported in protecting human
osteoarthritic and cartilage and chondrocytes [26].
Anti-inflammatory effects of ChondroT can be attrib-
uted to the action of all 5 herbs [27–31]. We evaluated
the remedial value of ChondroT compared with
GHJTY. The suppressive effect of ChondroT was
greater than that exhibited by GHJTY, and it showed
multifunctional therapeutic effects on inflammation
and arthritis. For standard validation of ChondroT, a
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Fig. 7 Anti-oxidant activity of ChondroT. ChondroT and other drugs
dissolved in methanol were mixed with DPPH (0.15 mM in methanol)
in 96-well plate for 30 min and then the absorbance was measured at
470 nm using an ELISA microplate reader. BHA and vitamin C were
used as positive anti-oxidant drugs. DPPH free radicals were decreased
by approximately 95 % at 0.3 mg/mL ChondroT, and the inhibitory
effect was greater than that exhibited by GHJTY. ***P < 0.001 compared
with the control group






























Fig. 6 Effects of ChondroT on PMA-induced NF-kB activation in 293T
cells. The 293T cells were transfected with a reporter plasmid, pNF-
kB-SEAP. PMA-induced NF- kB transcription, which was inhibited by
ChondroT at a concentrations of 0.3 and 0.1 mg/mL. *P < 0.05 and
**P < 0.01 compared with the PMA-treated group
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convenient and accurate HPLC–PDA detection method
was used for simultaneous determination of seven ref-
erence components. In conclusion, ChondroT treat-
ment increased chondrocyte proliferation, in part
through a reduction in oxidative damage. In addition,
ChondroT attenuated the severity of cartilage degrad-
ation factor. With its anti-inflammatory and anti-
oxidative properties, ChondroT may constitute a
promising therapeutic option for the management of
arthritis.
Conclusion
ChondroT exerted a chondroprotective effect and dem-
onstrated a multi-target mechanism involving effects
on inflammation and arthritis. In addition, the suppres-
sive effect was greater than that exhibited by GHJTY,
suggesting that ChondroT, a new complex herbal medi-
cation, has therapeutic potential for the treatment of
arthritis.
Abbreviations
BHA, butylated hydroxyanisole; Cel, celecoxib; COX-2, cyclooxygenase-2; DMEM,
Dulbecco Modified Eagle’s medium; DPPH, 2,2-diphenyl-1-picrylhydrazyl; ELISA,
enzyme-linked immunosorbent assay; FBS, fetal bovine serum; GHJTY,
Ganghwaljetongyeum; HPLC–PDA, high-performance liquid chromatography–
photodiode array; IL-1β, interleukin 1 beta; IL-6, interleukin 6; iNOS, inducible
nitric oxide synthase; LPS, lipopolysaccharides; MMP1, matrix metalloproteinase
1; MTS, 3-(4, 5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophe-
nyl)-2H-tetrazolium; NF-kB, nuclear factor kappa B; NO,nitric oxide; NSAIDs,
nonsteroidal anti-inflammatory drugs; PGE2, prostaglandin E2; PMA, phorbol
12-myristate 13-acetate; PVDF, polyvinylidene fluoride membranes; TBST, tris-
buffered saline and Tween 20; TNF-α, tumor necrosis factor-alpha; VtC, vitamin C
Funding
This study was supported by a grant (No. HI13C2285) of the Korea
Healthcare technology R&D Project, Ministry for Health & Welfare Affairs,
Republic of Korea.
Availability of data and materials
The datasets supporting the conclusions of this article are included within
the article.
Authors’ contributions
PJU carried out all the assays. KSJ, NCS, and CC participated in the design
of the study and performed the statistical analysis. SCS and SJK carried out
HPLC analysis of ChondroT. KBY helped to draft the manuscript. KYR
participated in its design and coordination and helped to draft the
manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Consent for publication
Not applicable.
Ethics approval and consent to participate
Not applicable.
Author details
1College of Pharmacy and Research Institute of Drug Development,
Chonnam National University, Gwangju 500-757, Republic of Korea. 2College
of Korean Medicine, Dongshin University, Naju-si 58245, Republic of Korea.
3Korea Institute of Oriental Medicine, Daejeon 34054, Republic of Korea.
4College of Pharmacy, Yeungnam University, Gyeongsan-si, Republic of
Korea.
Received: 12 March 2016 Accepted: 24 June 2016
References
1. Kim JH, Ryu KH, Jung KW, Han CK, Kwak WJ, Cho YB. Effects of SKI306X on
arachidonate metabolism and other inflammatory mediators. Biol Pharm
Bull. 2005;28(9):1615–20.
2. Sondergaard BC, Henriksen K, Wulf H, Oestergaard S, Schurigt U, Brauer R,
Danielsen I, Christiansen C, Qvist P, Karsdal MA. Relative contribution of
matrix metalloprotease and cysteine protease activities to cytokine-
stimulated articular cartilage degradation. Osteoarthritis Cartilage. 2006;14(8):
738–48.
3. Shin SS, Jin M, Jung HJ, Kim B, Jeon H, Choi JJ, Kim JM, Cho BW, Chung SH,
Lee YW, et al. Suppressive effects of PG201, an ethanol extract from herbs,
on collagen-induced arthritis in mice. Rheumatology (Oxford). 2003;42(5):
665–72.
4. Visse R, Nagase H. Matrix metalloproteinases and tissue inhibitors of
metalloproteinases: structure, function, and biochemistry. Circulation
research. 2003;92(8):827–39.
5. Zeng L, Wang W, Rong XF, Zhong Y, Jia P, Zhou GQ, Li RH.
Chondroprotective effects and multi-target mechanisms of Icariin in IL-1
beta-induced human SW 1353 chondrosarcoma cells and a rat osteoarthritis
model. Int Immunopharmacol. 2014;18(1):175–81.
6. Kobayashi M, Squires GR, Mousa A, Tanzer M, Zukor DJ, Antoniou J, Feige U,
Poole AR. Role of interleukin-1 and tumor necrosis factor alpha in matrix
degradation of human osteoarthritic cartilage. Arthritis Rheum. 2005;52(1):
128–35.
7. Martel-Pelletier J. Pathophysiology of osteoarthritis. Osteoarthritis Cartilage.
2004;12 Suppl A:S31–3.
8. Gosset M, Pigenet A, Salvat C, Berenbaum F, Jacques C. Inhibition of matrix
metalloproteinase-3 and -13 synthesis induced by IL-1beta in chondrocytes
from mice lacking microsomal prostaglandin E synthase-1. J Immunol. 2010;
185(10):6244–52.
9. Wu SQ, Otero M, Unger FM, Goldring MB, Phrutivorapongkul A, Chiari C,
Kolb A, Viernstein H, Toegel S. Anti-inflammatory activity of an ethanolic
Caesalpinia sappan extract in human chondrocytes and macrophages.
J Ethnopharmacol. 2011;138(2):364–72.
10. Moncada S, Palmer RM, Higgs EA. Nitric oxide: physiology, pathophysiology,
and pharmacology. Pharmacol Rev. 1991;43(2):109–42.
11. Keisuke I, Bian BL, Li XD, Takashi S, Akira I. Action mechanisms of
complementary and alternative medicine therapies for rheumatoid arthritis.
Chin J Integr Med. 2011;17(10):723–30.
12. Liu J, Liu RL. The potential role of Chinese medicine in ameliorating extra-
articular manifestations of rheumatoid arthritis. Chin J Integr Med. 2011;
17(10):735–7.
13. Funk JL, Oyarzo JN, Frye JB, Chen G, Lantz RC, Jolad SD, Solyom AM,
Timmermann BN. Turmeric extracts containing curcuminoids prevent
experimental rheumatoid arthritis. J Nat Prod. 2006;69(3):351–5.
14. Jeoung BR, Lee KD, Na CS, Kim YE, Kim B, Kim YR. Ganghwaljetongyeum, an
anti-arthritic remedy, attenuates synoviocyte proliferation and reduces the
production of proinflammatory mediators in macrophages: the therapeutic
effect of GHJTY on rheumatoid arthritis. BMC Complement Altern Med.
2013;13:47.
15. Choi W, Choi CH, Kim YR, Kim SJ, Na CS, Lee H. HerDing: herb
recommendation system to treat diseases using genes and chemicals.
Database (Oxford). 2016; 2016. doi:10.1093/database/baw011.
16. Lim HD, Kim YS, Ko SH, Yoon IJ, Cho SG, Chun YH, Choi BJ, Kim EC.
Cytoprotective and anti-inflammatory effects of melatonin in hydrogen
peroxide-stimulated CHON-001 human chondrocyte cell line and rabbit model
of osteoarthritis via the SIRT1 pathway. J Pineal Res. 2012;53(3):225–37.
17. Li J, Zhou XD, Yang KH, Fan TD, Chen WP, Jiang LF, Bao JP, Wu LD, Xiong Y.
Hinokitiol reduces matrix metalloproteinase expression by inhibiting Wnt/
beta-Catenin signaling in vitro and in vivo. Int Immunopharmacol. 2014;
23(1):85–91.
18. Zhuang C, Xu NW, Gao GM, Ni S, Miao KS, Li CK, Wang LM, Xie HG.
Polysaccharide from Angelica sinensis protects chondrocytes from H2O2-
induced apoptosis through its antioxidant effects in vitro. Int J Biol
Macromol. 2016;87:322–8.
19. Roh GS, Yi CO, Cho YJ, Jeon BT, Nizamudtinova IT, Kim HJ, Kim JH, Oh YM, Huh
JW, Lee JH, et al. Anti-inflammatory effects of celecoxib in rat lungs with
smoke-induced emphysema. Am J Physiol-Lung C. 2010;299(2):L184–91.
Park et al. BMC Complementary and Alternative Medicine  (2016) 16:213 Page 10 of 11
20. Xu XY, Jiang M, Zhang Y, Bi YL, Han MY. Celecoxib attenuates cachectic
events in mice by modulating the expression of vascular endothelial
growth factor. Mol Med Rep. 2015;11(1):289–94.
21. Solomon DH, Avorn J, Sturmer T, Glynn RJ, Mogun H, Schneeweiss S.
Cardiovascular outcomes in new users of coxibs and nonsteroidal
Antiinflammatory drugs - High-risk subgroups and time course of risk.
Arthritis Rheum-Us. 2006;54(5):1378–89.
22. Kisley LR, Barrett BS, Dwyer-Nield LD, Bauer AK, Thompson DC, Malkinson
AM. Celecoxib reduces pulmonary inflammation but not lung tumorigenesis
in mice. Carcinogenesis. 2002;23(10):1653–60.
23. Hartog A, Hougee S, Faber J, Sanders A, Zuurman C, Smit HF, van der Kraan
PM, Hoijer MA, Garssen J. The multicomponent phytopharmaceutical
SKI306X inhibits in vitro cartilage degradation and the production of
inflammatory mediators. Phytomedicine. 2008;15(5):313–20.
24. Kim JH, Ryu KH, Jung KW, Han CK, Kwak WJ, Cho YB. SKI306X suppresses
cartilage destruction and inhibits the production of matrix
metalloproteinase in rabbit joint cartilage explant culture. J Pharmacol Sci.
2005;98(3):298–306.
25. Lung YB, Seong SC, Lee MC, Shin YU, Kim DH, Kim JM, Jung YK, Ahn JH,
Seo JG, Park YS, et al. A four-week, randomized, double-blind trial of the
efficacy and safety of SKI306X: a herbal anti-arthritic agent versus diclofenac
in osteoarthritis of the knee. Am J Chin Med. 2004;32(2):291–301.
26. Kim JH, Huh JE, Baek YH, Lee JD, Choi DY, Park DS. Effect of Phellodendron
amurense in protecting human osteoarthritic cartilage and chondrocytes.
J Ethnopharmacol. 2011;134(2):234–42.
27. Choi YE, Ahn H, Ryu JH. Polyacetylenes from angelica gigas and their
inhibitory activity on nitric oxide synthesis in activated macrophages. Biol
Pharm Bull. 2000;23(7):884–6.
28. Jung HW, Mahesh R, Park JH, Boo YC, Park KM, Park YK. Bisabolangelone
isolated from Ostericum koreanum inhibits the production of inflammatory
mediators by down-regulation of NF-kappaB and ERK MAP kinase activity in
LPS-stimulated RAW264.7 cells. Int Immunopharmacol. 2010;10(2):155–62.
29. Lee CW, Park SM, Kim YS, Jegal KH, Lee JR, Cho IJ, Ku SK, Lee JY, Ahn YT,
Son Y, et al. Biomolecular evidence of anti-inflammatory effects by Clematis
mandshurica Ruprecht root extract in rodent cells. J Ethnopharmacol. 2014;
155(2):1141–55.
30. Lee JH, Ko WS, Kim YH, Kang HS, Kim HD, Choi BT. Anti-inflammatory effect
of the aqueous extract from Lonicera japonica flower is related to inhibition
of NF-kappaB activation through reducing I-kappaBalpha degradation in rat
liver. Int J Mol Med. 2001;7(1):79–83.
31. Bae S, Jung Y, Choi YM, Li S. Effects of er-miao-san extracts on TNF-alpha-
induced MMP-1 expression in human dermal fibroblasts. Biol Res. 2015;48:8.
•  We accept pre-submission inquiries 
•  Our selector tool helps you to find the most relevant journal
•  We provide round the clock customer support 
•  Convenient online submission
•  Thorough peer review
•  Inclusion in PubMed and all major indexing services 
•  Maximum visibility for your research
Submit your manuscript at
www.biomedcentral.com/submit
Submit your next manuscript to BioMed Central 
and we will help you at every step:
Park et al. BMC Complementary and Alternative Medicine  (2016) 16:213 Page 11 of 11
